innovations during the drug
discovery phase.
We take a personalized and integrated approach to help our clients position their pipelines and companies for success offering a full range of development and commercialization services.
We are Halloran, a life science consulting firm, partnering to enrich your product development and business growth. We propel your organization further; positively impacting the health and wellbeing of patients around the world.
![]() |
Director, Business Development Director, Business Development |
Kelly Hagen serves as Director of Business Development at ProductLife Group (PLG), where she partners with pharmaceutical, biotechnology, and life sciences organizations to support their regulatory, quality, and product development initiatives. With nearly two decades of experience in healthcare and life sciences business development, Kelly is known for helping companies identify strategic opportunities and connect with the expertise needed to successfully navigate complex regulatory and development pathways.
Throughout her career, Kelly has held multiple director-level roles focused on business development, strategic partnerships, and growth within the life sciences sector. She also brings experience in mergers and acquisitions, supporting the identification and evaluation of strategic opportunities that help organizations expand capabilities and strengthen their market position.
At PLG, Kelly works closely with pharmaceutical, biotechnology, and medical device companies to understand their development and regulatory challenges and align them with PLG’s global expertise across regulatory affairs, pharmacovigilance, quality, and clinical development services. Her consultative approach and deep industry knowledge enable her to build trusted relationships with clients, accelerate product development, and bring new therapies to market.
Kelly holds a Bachelor’s degree in Communication Sciences from the University of Connecticut.